NCT02981368 · OUTCOME

Area Under the Plasma Concentration Versus Time Curve (AUC) of 18F-DCFPyL in a Subset of Participants

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer · Source last updated 2021-08-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEAN
Unit: h*μCi/ml
Interval / dispersion: Standard Deviation
Time frame: Samples were collected at 0, 5, 15, 30, 60, 120, 240, 360, and 480 minutes after administration of 18F-DCFPyL.

Analysis population: Ten (10) participants from a single investigational site with high risk localized prostate cancer scheduled to undergo radical prostatectomy with pelvic lymph node dissection (Cohort A) agreed and were consented to participate in the PK portion of the study.

Groups in this outcome

Pharmacokinetic Subset of High Risk Prostate Cancer Participants (Cohort A)

A subset of high risk prostate cancer participants planned for radical prostatectomy with pelvic lymph node dissection (Cohort A) participated in the pharmacokinetic portion of the study.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Pharmacokinetic Subset of High Risk Prostate Cancer Participants (Cohort A)	10

Reported measurements

Source class 1

Values in h*μCi/ml · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Pharmacokinetic Subset of High Risk Prostate Cancer Participants (Cohort A)	0.82	0.143	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
spread
0.143
value
0.82

denoms

counts
group Id
OG000
value
10
units
Participants

dispersion Type

Standard Deviation

groups

description
A subset of high risk prostate cancer participants planned for radical prostatectomy with pelvic lymph node dissection (Cohort A) participated in the pharmacokinetic portion of the study.
id
OG000
title
Pharmacokinetic Subset of High Risk Prostate Cancer Participants (Cohort A)

param Type

MEAN

population Description

Ten (10) participants from a single investigational site with high risk localized prostate cancer scheduled to undergo radical prostatectomy with pelvic lymph node dissection (Cohort A) agreed and were consented to participate in the PK portion of the study.

reporting Status

POSTED

time Frame

Samples were collected at 0, 5, 15, 30, 60, 120, 240, 360, and 480 minutes after administration of 18F-DCFPyL.

title

Area Under the Plasma Concentration Versus Time Curve (AUC) of 18F-DCFPyL in a Subset of Participants

type

SECONDARY

unit Of Measure

h*μCi/ml

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice